• Industry experts say sales of both new and used vehicles have dropped by more than 50 percent at the end of April 2020 compared to the same time in 2019
• Increasingly motivated to sell, car makers and dealers are offering special deals to entice buyers, including zero-percent financing on multiple models
• PowerBand Solutions’ cloud-based platform helps users get access to such deals online by streamlining vehicle sale interactions among participants and eliminating unnecessary middlemen

With 26 million Americans having lost their jobs in the wake of the coronavirus outbreak and another 25% expecting to lose theirs in the near future, people are hesitant to make or even plan for making major purchases such a new car, but, as Warren Buffett said, “Be greedy when others are fearful and fearful when others are greedy.”

The truth is, there has been no better time to land a deal on a new car than now, according to a MarketWatch report (http://ibn.fm/zpZMB), and PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) is there to facilitate any transaction safely and swiftly via its cloud-based auto trading platform, which can be used from smartphones and other digital devices, from any location. That’s good news in the social distancing brought on by the pandemic.

Buying a car may normally includes test drives and multiple trips to the dealership, but social distancing rules imposed by the pandemic have made the customary practices impossible, leaving car makers and dealerships struggling. According to one estimate provided by Cox Automotive, new car sales were down 59 percent year over year and used car sales were down 53 percent at the end of April (http://ibn.fm/u3J0o).

As a result, both auto makers and dealers are very motivated to sell and are already offering special deals and online options to entice buyers. Companies like Chevrolet are offering zero percent financing, which means you’ll only be paying off the principal of a car loan. Hyundai also has a no-interest 84-month offer and deferred payments for four months. Fiat Chrysler Automobiles has a zero percent financing, 84-month offer on some 2019 and 2020 vehicles. Kia has a zero percent financing for 75 months offer on certain models, according to the MarketWatch report. To better understand the significance of these offers, it should be noted that car loan rates were between five and six percent as recently as Q4 2019 (http://ibn.fm/KXFx4).

While many dealerships are open, consumers are beginning to demand more ecommerce options in the name of convenience and in light of the restrictions enforced by the pandemic. Ecommerce is already changing the ways in which manufacturers, dealers, and digital car sellers offer customers new and used cars. The compound annual growth of digital sales was 7.61% from 2015-19 compared to 1.73% for total sales. According to the Digital Commerce 360 Online Vehicle Shopper 2019 survey, 49% of buyers are willing to purchase a new vehicle entirely online, while Frost & Sullivan estimates that consumers will be able to purchase as many as 1.3 million vehicles online annually as soon as 2035 (http://ibn.fm/l7GUo).

PowerBand Solutions’ cloud-based auto transaction platform successfully addresses this growing need to sell and buy vehicles online. Developed by a team of experienced automotive, technology and finance experts, the platform was created around the core belief that consumers preferred to conduct automotive transactions online and avoid interactions with unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles with never-seen-before simplicity, speed and cost-efficiency from their smartphones or other devices, irrespective of their location.

The company is working on commercializing its platform to consumers and automotive dealers and to this end, it has secured a more than $2 million investment from Texas-based D&P Holdings Inc. – one of the largest administrators of automotive warranty and insurance products in the United States, working with more than 850 dealerships nationwide (http://ibn.fm/fpVSH).

The company’s cloud-based platform will soon be advertised across the United States via a partnership with Source Digital, a pioneer in immersive commerce through the use of digital media platforms and video content on the internet. This unique campaign will use Source’s patented technology to promote PowerBand’s platform inside popular video content with various channels and influencers in the U.S. (http://ibn.fm/S686J).

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

• U.S. vehicle sales totaled about $1.1 trillion in 2019
• 49% of consumers state they are willing to purchase a new vehicle online
• PowerBand Solution’s cloud-based platform streamlines vehicle sale interactions among participants and eliminates unnecessary middlemen

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has launched a new platform in the cloud that lets people buy and sell cars and trucks with never-seen-before simplicity, speed, and cost-efficiency. This breakthrough is in line with the growing trend of ecommerce, which is set to change automotive retailing in a major way.

Vehicle trade may be one of the last sectors to be impacted by ecommerce, but ecommerce definitely won’t pass it by. It is already beginning to change the ways in which manufacturers, dealers, digital car sellers and others sell new and used cars to customers (http://ibn.fm/x8nwS).

Forty-one major car makers sell cars, trucks and sport utility vehicles in the U.S. They do this mainly through a network of approximately 17,000 dealerships, according to the National Dealers Automotive Association. So far, websites have mostly been used as a marketing and sales generation channel to attract car shoppers to the dealership’s physical location, where the shopper buys the vehicle.

But PowerBand has realized this is already changing, as a growing number of consumers are turning towards online and ecommerce options, in the name of convenience and in light of the restrictions enforced by the current pandemic. According to the ‘Digital Commerce 360 Online Vehicle Shopper 2019’ survey, conducted among 1,089 buyers, 49% are willing to purchase a new vehicle entirely online (http://ibn.fm/CrCnZ).

Automotive ecommerce is already a sizable market, generating online sales of approximately $14.6 billion in 2018, and it has plenty of room for growth, having the potential to take up a sizable piece of the total automotive transaction market, which reached $1.1 trillion in 2019, according to the U.S. Department of Commerce (http://ibn.fm/YfUuB). The compound annual growth of digital sales was 7.61% from 2015-19 compared to 1.73% for total sales. What is more, this is only the beginning of the trend to buy vehicles online. According to Frost & Sullivan, consumers may purchase as many as 1.3 million vehicles annually online as soon as 2035.

PowerBand Solutions has been one of the first companies to cater to this growing need to sell and buy vehicles online. Developed by a team of experienced automotive, technology and finance experts, PowerBand’s cloud-based transaction platform was created around the core belief that consumers prefer to conduct automotive transactions online and avoid interactions with unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles from their smart phones or other devices, irrespective of their location.

PowerBand has already successfully launched and conducted ‘virtual’ auctions in the United States together with and D2D Auto Auction LLC. D2D is co-owned by PowerBand and Arkansas-based financier Bryan Hunt, director of J.B Hunt Transport. The highly successful virtual auctions, held on April 7th and April 16th, testified to the speed and efficiency of D2D’s unique transaction platform (http://ibn.fm/sDYYv).

The company is now rolling out the platform across the United States, having partnered to this end with Source Digital, a pioneer in immersive commerce through the use of digital media platforms and video content on the internet. This unique campaign will use Source’s patented technology to promote PowerBand’s platform inside popular video content with various channels and influencers in the U.S. (http://ibn.fm/ixcaO).

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

• Well-positioned to capitalize upon the bullish nature of the gold sector; offers potential for silver as well
• Delivering high-quality, diversified exposure and growth optionality in relation to precious metals
• Capitalizing on strong commodity cycles
• Promoting responsible mining practices and supporting surrounding communities
• Uncovering hidden gems to revitalize America’s past precious metals producers
• Offering potential for additional growth through acquisition of new exploration targets
• Exploring and expanding on the success of the historical mines and prospects underlying the Company’s current agreements
• Leveraging an experienced management team with a strong track record of proven success
• Positioning for further growth and to take advantage of the steady increase in demand for gold

Kingman Minerals Ltd. (TSX.V: KGS), formerly Astorius Resources Ltd., is engaged in the acquisition, exploration and development of gold and silver properties in North America. The Canada-based company is focused on sourcing and developing high-quality properties in favorable mining locations to advance its diverse portfolio of low-cost, lifelong assets.

The Company maintains the following projects:

The Mohave Project: Located in the Music Mountains in Mohave County, Arizona. Approximately 35 miles from the town of Kingman, the property consists of 20 lode claims, including the historic Rosebud Mine. The Company has entered into an option agreement to earn 100% over four years. According to historic mappings of the mine, probable ore is 15,560 tons. Possible (inferred) ore is comprised of 176,000 tons, and additional possible (inferred) ore totals slightly over 1,100,000 tons. The total contained gold ounces for all categories is estimated at 664,000 ounces, and contained silver is estimated at 2,600,000 ounces. The Company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying previous resource estimates.

The Cadillac East Property: Located approximately 55 kilometers east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The Company acquired a 100% interest in the property from an arm’s length vendor. Cadillac East Property consists of 12 claims, and the Company has an option agreement to earn 100% over three years. Having been the subject of numerous geophysical and geological surveys, the Cadillac East Property has been explored and surveyed by numerous companies as well as by the Quebec government. Exploration work done in 2017 by Exploration Facilitation Unlimited Inc. revealed multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.

Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in Forbes Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral exploration methods with strategic partners throughout the United States and the world.

Gold’s Predicted Rise

The value of gold is currently on an upward climb due to COVID-19’s upending of the global economy, causing governments to expand their balance sheets. In 2019, as a result of the housing and financial crisis, gold saw its best performance since 2010 — increasing as much as 20% and hitting a top price of $1,549 per ounce in September of that year. Analysts predict its price will continue to climb due to strong buying by central banks, a weakening of the U.S. dollar, and increasing political tensions. A recent Wolfe Research report predicted gold would hit an all-time high, referencing an ounce of gold that commanded a $1,515 asking price. As the value of the U.S. dollar weakens, the demand for gold is inversely rising. Known as a safe-haven asset, gold tends to see increased levels of demand during times of consumer fear or recession.

Management

Sandy MacDougall – Chairman and Director
An economics graduate from the University of British Columbia, Sandy MacDougall brings 30+ years of experience in the investment banking and finance industry to KGS. He was instrumental in the acquisition, development and production of gold at the Alto el Toro mine near Ibaguel, Columbia. As a former investment advisor at Canaccord Capital Corp., MacDougall was a key player in multiple significant financings in Canada as well as abroad, working with a wide range of companies. His experience has afforded him critical exposure to precious and base metal projects throughout North and South America, and he has served as chairman of the board since 2016.

Arthur Brown – President and Director
With 36 years of business experience and service to the boards of eight other companies in sectors ranging from technology to oil, gas and mineral exploration, Arthur Brown adds substantial knowledge in corporate structure and development as well as financings and venture capital to the KGS team.

Cyrus Driver – Independent Director
Cyrus Driver was a founding partner in the firm of Driver Anderson from its inception in 1982 and is a chartered accountant as well as a retired partner in the firm of Davidson and Company LLP. Aside from providing general public accounting services to a diverse range of clients, his specialty is servicing TSX Venture-listed companies and members of the brokerage community. With expert knowledge of the securities industry and its regulations, Driver lends valuable advice to his clients regarding finance, taxation and other accounting-related matters. He currently serves as director and chief financial officer of several TSX.V-listed companies.

Dr. Peter Born – Director and Technical Specialist
A professional geologist registered with the Association of Professional Geoscientists of Ontario and a fellow of the Geological Association of Canada, Dr. Peter Born brings 30+ years of experience in exploration and mining to the company. With prior roles as a senior geologist with Western Mining Corporation, he is currently working with RPS Energy Canada Ltd. on natural gas plays related to high-temperature dolomites and sedimentary zinc deposits (MVT) within the Appalachian Basin in the United States. Dr. Born holds a Ph.D. in earth sciences and has expertise in Precambrian sedimentary geology, basin analysis, sedimentology, stratigraphy and sedimentary ore deposits.

For more information, visit the company’s website at www.KingmanMinerals.com

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

• SHRG announces Elevate MAX(TM), newest featured beverage in Elevacity nootropic product line
• ‘Happy coffee’ targets increasing consumer demands for additional functional beverages with potential health benefits such as weight management, mood enhancement, extreme energy
• New beverage features its D.O.S.E. formulation, designed to increase levels of key hormones associated with happiness

Sharing Services Global Corporation (OTCQB: SHRG) recently unveiled its newest product – Elevate MAX, a new featured beverage in its Elevacity nootropic product line. Launched during SHRG’s Happiness Revolution LIVE virtual event, product sales for the new offering have exceeded expectations and outperformed all prior product launches (http://ibn.fm/oTMh8).

Elevate MAX is more than just a cup of coffee; this ‘happy coffee’ targets increasing consumer demands for additional functional beverages with potential health benefits such as weight management, mood enhancement and extreme energy (http://ibn.fm/qwDVY).

“We completed extensive market research with outstanding results and are pleased to report the sales of Elevate MAX has exceeded our expectations and surpassed any prior product launches,” Keith Halls, president and CEO of Elepreneurs Holdings LLC, the sales and marketing subsidiary that manages and operates the network of distributors selling the Elevacity product line, stated in a news release.

The newest addition to Elevacity’s line of beverages features the company’s D.O.S.E. formulation, designed to increase levels of four key hormones – dopamine, oxytocin, serotonin and endorphins – proven to be associated with happiness. In addition, the exclusive beverage contains the following (http://ibn.fm/bsIOv):

• A strong blend of polyphenol extracts including apple, grape and mango combined with green tea catechin extract, essential to support and regulate immune functions in the body
• P-synephrine, an efficacious ingredient that acts as a nonstimulant thermogenic agent to increase the breakdown of fats and works synergistically with caffeine to improve exercise performance.
• Adaptogen rhodiola rosea root extract, a natural substance known to increase resistance to stress.

Targeted to assist in enhancing mood, suppressing appetite, strengthening the immune system, and reducing levels of stress while increasing levels of energy, Elevate MAX is the most recent addition to a strong Elevacity product line that was initially released in December 2017. The mission of Elevacity, a wholly owned subsidiary of Sharing Services, is to provide SHRG’s independent sales force, called Elepreneurs, with the safest, most efficacious products formulated to elevate the lives of consumers and Elepreneurs alike. The Elevacity line of functional beverages and supplements are all designed around the company’s proprietary D.O.S.E. formulation and include nonaddictive, natural ingredients with no additives or fillers.

Sharing Services Global Corporation is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. Two of its primary divisions include Elevacity Holdings and Elepreneurs Holdings LLC, a sales and marketing company based on utilization of independent contractor distributors who sell the Elevacity product line.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• POAI subsidiary Helomics helps oncologists individualize cancer treatment using patient-derived tumor models to improve outcomes
• Helomics’ tumor genomic and drug response database is one of the largest in the world with over 150,000 tumors across 137 cancer types
• Expected CAGR of 10.3% from 2018-2024 for oncology segment of precision medicine industry

The relationship between a patient and their cancer is personal: it’s specific, and it necessitates personalized treatment to be defeated effectively. Unfortunately, oncologists’ ability to personalize treatment for patients has largely been anything but, often resembling a trial-and-error method. This is largely because we have few targeted treatments or enough actionable data about how tumors with specific mutations respond to drugs. One innovator in the cancer research space, Predictive Oncology Inc. (NASDAQ: POAI), is working to change this dynamic by bringing its cutting-edge, AI-driven predictive models of tumor drug response and outcome to cancer research. These models predict how tumors respond to drugs and can be used for both clinical decision support, i.e. individualizing a patient’s therapy as well as research into new therapies, in partnership with the pharmaceutical and biotech industries.

With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own living tumor to address challenges oncologists often face when assessing patients and individualizing treatments. The clinically validated (in ovarian cancer) cell-based functional platform is in use today and profiles patient tumors, identifying key biomarkers and how the tumor responds to drugs and helps the oncologist determine a tailored therapy for that patient.

Helomics’ is building AI-driven predictive models by leveraging; a unique database of 150,000 tumor genomic and drug response profiles gathered from over 15 years of clinical testing using its TruTumor platform; access to over 15 years of outcome data from a national network of oncologists; plus a physical biobank of tumor samples that is being sequenced as part of its CancerQuest 2020 initiative (http://ibn.fm/B9mmE) to generate rich genomic profiles.

Along with subsidiaries TumorGenesis and Skyline Medical, POAI brings precision medicine to the treatment of cancer through collaborations with key players in the pharmaceutical, diagnostic and biotech industries. According to Mordor Intelligence Inc, oncology is expected to have the largest share of the precision medicine industry with estimated market dominance in excess of 30% over other precision medicine segments, and a CAGR of 10.3% from 2018 to 2024 (http://ibn.fm/8fqiH).

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• SRAX conducted two surveys using consumer-driven BIGtoken platform
• Mother’s Day study showed 68% of users purchased gifts, 49% bought online
• COVID-related survey reveals 67% of users afraid of early reopening, 32% intend to immediately purchase non-essential services
• BIGtoken platform encompasses 16 million users across more than 30 countries with $400 million potential projected revenue by January 2022

As a global society adapts to COVID-19 restrictions, consumer patterns and preferences continue to shift – and insights into these changes are more sought-after than ever before. Brands across all industries seek to leverage valuable consumer data to increase sales, and companies like SRAX Inc. (NASDAQ: SRAX), a technology company focused on digital marketing and consumer data management, have valuable resources to meet this need. SRAX recently released two studies showing key insights about changing consumer patterns in connection with the COVID-19 panic. Through the use of its BIGtoken platform, SRAX leverages the consumer data of its 16 million users to create valuable data sets that are accessible by marketers for a fee. The company also compensates its users with cash or gift cards when they opt in and give access to their data.

The first BIGtoken study was conducted with Publicis Groupe, one of the largest marketing and communications companies in the world (http://ibn.fm/dd3jV). Using BIGtoken’s Lightning Insights, millions of consumers were surveyed to analyze their buying activities surrounding Mother’s Day, giving insight into how the current economic conditions are affecting consumption patterns. While the results showed that 70% of the study participants felt Mother’s Day was either ‘neutral’ or ‘not important’, 84% still celebrated the day, 68% bought a gift, and 49% made that purchase online.

In addition to the Mother’s Day survey, the BIGtoken platform was also leveraged to research the sentiments of users regarding the reopening of the United States (http://ibn.fm/I8Nq6), revealing that 67% feared it will lead to an increased spread of the coronavirus while 32% intend to immediately purchase non-essential goods and services once the country reopens. According to the survey, the types of businesses that users intend to visit include state parks and beaches (39.7%), supermarkets and banks (37.2%), barber shops and nail salons (33.3%), restaurants (29.5%), and non-essential retail stores (25.6%).

The unprecedented economic landscape created by COVID-19 and the resulting lockdown has prompted many companies to seek unique insights into consumer behavior so they can adapt to the increasingly challenging business environment. Data gleaned from SRAX’s BIGtoken platform provides valuable consumer insights, allowing brands to draw inferences to inform their marketing strategy.

“BIGtoken is happy to play a role in helping brands understand rapidly changing consumer behaviors during this time,” BIGtoken Executive Vice President George Stella stated in a recent news release. “Because our users are compensated as they share their data, we’re proud to put a little money back in their pockets. We look forward to continuing to use our platform to help in this crisis by connecting brands directly with their customers and providing quick, relevant insights and audiences they can activate.”

With over 16 million users across more than 30 countries, SRAX’s BIGtoken platform compensates users in addition to providing brands the ability to target and access specific niche groups across 25,000 unique market segments with the power to submit specialized queries that include location and purchase history. Potential revenue for BIGtoken is projected at $400 million by January 2022, with plans to formally launch into several international markets that include Europe, India and Mexico.

Along with BIGtoken, SRAX also unlocks data for the finance space through Sequire – its premier platform for investor intelligence and communication that allows public companies to track investor behaviors and trends for use in engaging current and potential investors.

With an aim to deliver the tools to unlock the value of data, SRAX’s technology helps brands gain insights across marketing channels in the consumer goods, investor relations, luxury, and lifestyle verticals.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Preparing for a record-breaking active hurricane season in Florida
• Working to stop the destructive cycle of storm waste in landfills and disposal sites
• Starting storm season in solid position with recent acquisition, three long-term contracts already in place

While the majority of companies have their eyes on COVID-19 and what recovery from “stay-at-home” orders look like, National Storm Recovery Inc. (OTC: NSRI) is preparing for what looks to be an active hurricane season in Florida.

April 2020 set heat records across the world. According to the National Oceanic and Atmospheric Administration (NOAA), 2020 is set to be earth’s warmest year on record while the European Union’s Copernicus Climate Change Service predicts it will rank as one of the top two (http://ibn.fm/cmj5I). Florida was no exception setting with high-temp records set across the state. Typically, higher temps forecast an active hurricane season as heat and warm ocean water play vital roles in powering the storms. The NOAA has reported that the strip of ocean where hurricanes begin was a full 1.1 degrees Celsius warmer than average.

How does all of this effect hurricane season? An article in the Miami Herald (http://ibn.fm/tMeUZ) quoted Michael Mann, director of the Earth System Science Center at Pennsylvania State University, who stated, “We have these bathtub-like conditions of extreme warmth combined with a La Nina-like state of the climate system. In our statistical model, it’s the same sort of condition we saw in 2005.” The center is predicting anywhere from 15 to 24 hurricanes, with 20 named storms in 2020. In 2005, the United States experienced five hurricanes that made landfall, one of which was Katrina.

Historically storm-waste disposal has created an environmental burden on landfills and disposal sites around the nation, only adding to the problem of climate change and the conditions that create these destructive storms. National Storm Recovery, headquartered in Florida, has created a synergistic and environmentally beneficial solution to stop the cycle. The company collects tree debris that is then processed for recycling and manufacturing into organic, next-generation mulch products that are sold to retailers, landscapers, installers and garden centers.

NSRI is used to weathering storms, and as the company prepares for the upcoming hurricane season, it does so in a solid position. The company recently acquired Mulch Manufacturing and has three long-term contracts already in place: a three-year agreement with one of the largest waste disposal companies to lease their yard waste facility; a three-year contract with two one-year renewals for emergency debris and tree removal services for the town of Oakland, Florida; and a three-year contract with two one-year renewals for tree trimming and removal services for Orange County [Florida] Public Schools (http://ibn.fm/Ie3Yf).

NSRI has proved to be a formidable force amid the storms the United States is facing. Whether those storms are founded in economics or Mother Nature, NSRI has a firm foundation and is standing ready to make a difference for customers, employees and shareholders.

For more information, visit the company’s website at www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

• SHRM announces recent acquisition of California-based Ketamine Wellness Clinic of Orange County Inc.
• CEO calls acquisition major milestone as company accelerates vision of establishing sizable footprint of integrated ketamine clinics
• Center is recognized leader in ketamine infusion therapy, research and complementary treatment protocols

With the announcement of its recent acquisition of the Ketamine Wellness Clinic of Orange County Inc., Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) is taking steps to expand into the United States (http://ibn.fm/rFEOp). The wellness clinic owns and operates a state-of-the-art ketamine infusion treatment center located within the Mission Hospital’s Laguna Beach campus.

“We are thrilled to begin executing on our North American expansion strategy by acquiring our first U.S.-based, revenue-generating ketamine center, the Wellness Clinic of Orange County,” SHRM CEO Dr. Roger McIntyre stated in a news release. “This acquisition represents a major milestone as we begin to accelerate our vision of establishing significant scale and a sizable footprint of integrated ketamine centric clinics committed to providing innovative care and therapeutic options to improve the quality of life of patients suffering from chronic disease states that have failed conventional treatments.”

A Canada-based company dedicated to applying novel and natural treatment protocols with an emphasis on psychedelic medicine, Champignon outlined the acquisition in a term sheet completed with the wellness clinic, a cutting-edge facility that has become a recognized leader in ketamine infusion therapy and is actively involved in research and complementary treatment protocols. Based on impressive peer-reviewed studies and equally attention-grabbing clinical trials, intravenous ketamine has gained prominence as a promising treatment option for many chronic diseases, including depression, anxiety, post-traumatic stress disorder, fibromyalgia and certain pain disorders.

“This is an exceptional opportunity to both collaborate and scale with Dr. McIntyre and the world-class team at Champignon, with the objective of remaining at the forefront of innovation in this burgeoning field,” added Dr. Michael Bronson of the Ketamine Wellness Clinic of Orange County. “We are excited for our patients, both current and future, as we work to provide them with the therapeutic options that they deserve.”

As outlined in the term sheet, Champignon is set to acquire 100% of the clinic and all subsidiary companies of the wellness clinic in exchange for a combination of payments and common shares spread over an 18-month period. The completion of the agreement is subject to several conditions, including but not limited to the execution of a definitive agreement and completion of satisfactory due diligence.

Champignon seeks opportunities to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health-care and pharmaceutical products. The company’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom industry with a selection of mushroom-infused teas and accessories; SHRM is also expanding its preclinical trial pipeline and branching out into alternative medicine and pharmaceuticals.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

• Software applications among key 3D printing growth trends for 2020
• SGLB’s PrintRite3D(R) software provides manufacturers with quality control solutions that can be remotely deployed throughout entire supply chain to any location worldwide
• Software solutions for 3D printing estimated at $1.4 billion, expected to exceed $3.9 billion by 2023

Despite the current global economic slowdown, the outlook for 3D printing remains optimistic, according to a recent article highlighting areas of growth for 2020 (http://ibn.fm/lLBgY). Most notably, trends like new product creation, increased aftermarket supply chains, and the race to create novel software applications that monitor quality control are predicted to take center stage. Sigma Labs Inc. (NASDAQ: SGLB), a leading provider of software solutions for the 3D metal printing industry, is positioned to benefit from growth in application development – a key trend – with its patented PrintRite3D(R) software that provides manufacturers with a consistent standard of quality assurance. Sigma Labs’ technology is capable of being remotely deployed throughout the entire supply chain to any location in the world.

Quality control solutions are vital for the industry to realize profits and achieve scale due to the high costs of rejected output and time spent in post-production inspections. With an estimated addressable market of $1.4 billion that is projected to exceed $3.9 billion by 2023, software development remains a key growth factor for the 3D metal printing industry. Accordingly, the venture capital market has shifted focus from hardware to application development, with over $1 billion raised by startups in 2019 and continued flows expected for 2020.

Despite the prevailing economic conditions, investment interest in 3D printing remains high. From its demonstrated flexibility in production, quickly providing medical supplies onsite to its ability to eliminate lengthy procurement processes or long shipping wait times, the technology offers critical solutions to longstanding industry woes (http://ibn.fm/znKmn).

Despite these benefits, quality control still continues to be a primary impediment to full industrialization due to a set of challenges that include a lack of product uniformity, profits lost due to rejected output, and costs associated with time spent in the post-production inspection phase. The 3D printing process creates objects by applying layers of raw material on top of each other, making in-process quality control measures absolutely critical for detecting anomalies in real time to allow for error correction. With its patented PrintRite3D(R) software, SGLB is an industry leader in the provision of quality control solutions that give operators the critical information required to observe the production process and address errors or anomalies taking place in real time. By enabling remote production from any location in the world, PrintRite3D(R) empowers operators to identify and fix machine inconsistencies during the printing process throughout the supply chain, so production can be optimized and modified in real time to produce higher quality yields, thus increasing profits.

PrintRite3D(R) runs on most major brands of 3D metal printers from different manufacturers, allowing for a standardized quality assurance process that can be deployed across the entire production chain. Created specifically for highly demanding precision-focused industries, PrintRite3D(R) is currently being evaluated by tier-1 manufacturers in the defense, aerospace, oil and gas, transportation and biomedical industries.

Founded by a team of Los Alamos National Labs scientists and engineers, Sigma Labs, Inc. originally developed and commercially licensed advanced metallurgical products prior to entering the additive manufacturing industry. As a leading provider of quality assurance software under the PrintRite3D(R) brand, SGLB’s stated objective is to become the de facto provider of quality assurance software to the 3D metal printing industry.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• SHRM appoints top depression researcher as new chief executive officer
• McIntyre established Canada’s first-ever center to provide rapid-onset treatments for individuals with mood disorders
• Champignon also announces appointment of new board member

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated applying novel and natural treatment protocols with an emphasis on psychedelic medicine, has appointed one of the world’s top researchers on depression as its new chief executive officer (http://ibn.fm/rureS). In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon.

“My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,” McIntyre stated in a news release. “The clinical infrastructure, complementary asset base and human capital that Champignon has acquired leaves me very confident we will provide life-changing treatments for persons with depression, all the while contemporaneously rewarding our investor base.

“I have been honored as a professor of psychiatry and pharmacology at the University of Toronto, as well as a professor at universities across the United States and Asia and currently head the world’s largest clinical R&D network in depression,” McIntyre continued. “The Canadian Rapid Treatment Centre of Excellence [CRTCE], that I envisaged and successfully implemented, is the world’s first integrated clinical and R&D centre in ketamine and psychedelic-based treatments and is identified as the most influential scientific center for depression research.”

A professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto, McIntyre also serves as executive director of the Brain and Cognition Discovery Foundation in Toronto; director and chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA) in Chicago, Illinois.; professor and Nanshan scholar at Guangzhou Medical University; and adjunct professor at the College of Medicine at Korea University. McIntyre is also a clinical professor at the State University of New York (SUNY) Upstate Medical University, Syracuse, New York, and a clinical professor in the Department of Psychiatry and Neurosciences, at the University of California Riverside School of Medicine.

McIntyre has been named one of the World’s Most Influential Scientific Minds each year from 2014 to 2019 by Clarivate Analytics. He is renowned as one of the world’s most recognized psychiatrists in relation to mood disorders, and has garnered extensive experience collaborating with private-sector partners, including those in the pharmaceutical, insurance and health-care industries.

“We are extremely pleased and fortunate to be able to bring Dr. McIntyre aboard as CEO,” added Gareth Birdsall, who has been serving as Champignon CEO and will continue in his service as director of Champignon. “Dr. McIntyre is the world’s leading authority on depression and associated mood disorders, which is further crystalized by his foresight in founding Canada’s first integrated mood disorder treatment and integrated research center in the CRTCE. Dr. McIntyre’s clear ability to execute and his entrepreneurial nature, along with a demonstrated capacity to lead and delegate in dynamic and growing organizations, represent the skill sets that Champignon needs as it moves towards our North American clinic expansion and maturing novel drug discovery initiatives.”

In addition to the appointment of McIntyre, SHRM also announced that it had appointed Pat McCutcheon as a member of its board of directors (http://ibn.fm/SHUNQ). McCutcheon currently serves as CEO of MediPharm, a leading global cannabis company. McCutcheon founded MediPharm with the objective of building the first pure-play cannabis company focused solely on extraction and API manufacturing.

“I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” said McCutcheon. “I look forward to working with the board and the company’s management team to advance Champignon’s clinical development and expansion program in the US and Canada. I also look forward to assisting the company with its plan to evaluate other assets and new partnerships that will expand its pipeline in the rapidly emerging ketamine and psilocybin for mental health industry that has demonstrated strong potential in a short period of time.”

Prior to his work at MediPharm, McCutcheon held top management roles with several large pharmaceutical companies, including Jansen Pharmaceuticals (Johnson & Johnson), Sanofi and Astra Zeneca, where he was directly responsible for launching a wide range of medical products.

“We are tremendously pleased to have Pat join the Champignon Board,” said Birdsall. “His extensive experience in commercial development across the pharmaceutical industry combined with direct experience operating and scaling highly profitable businesses further strengthens our board with expertise that will accelerate the expansion of our clinical footprint via the establishment of net new clinical entities, as well as industry partnerships for ketamine, psilocybin and MDMA.”

Champignon seeks opportunities to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health-care and pharmaceutical products. The company’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom industry with a selection of mushroom-infused teas and accessories; SHRM is also expanding its preclinical trial pipeline and branching out into alternative medicine and pharmaceuticals.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM